Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Sensei Biotherapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
Revenues30.40.00.08.48.2
            Revenue growth  -100.0%1.5% 
Cost of goods sold50.20.00.016.712.7
Gross profit-19.80.00.0-8.4-4.5
            Gross margin-65.2%  -100.0%-54.9%
Research and development 21.711.2  
General and administrative19.815.87.54.14.5
EBIT-50.2-37.5-18.7-12.4-12.7
            EBIT margin-165.2%  -148.9%-154.9%
Pre-tax income-48.6-36.8-20.1-16.7-13.0
Income taxes0.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%
Net income-48.6-36.8-20.20.00.0
            Net margin-159.9%  -0.2%-0.2%
 
Diluted EPS($1.58)($1.33)($12.53)($55.92)($45.87)
Shares outstanding (diluted)30.727.71.60.00.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy